Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer
Globe Newswire29-06-2023, 12:59
Acronis Achieves Remarkable Expansion in Mexico with Significant 53% Revenue Growth 24-10-2024, 21:00